TY - JOUR
T1 - Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas
AU - Yao, Li
AU - Barontini, Marta
AU - Niederle, Bruno
AU - Jech, Marion
AU - Pfragner, Roswitha
AU - Dahia, Patricia L.M.
N1 - Funding Information:
P.L.M.D. is a Kimmel Foundation Scholar and a Voelcker Foundation Young Investigator and is supported by the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (NIH-P30 CA54174) .
PY - 2010/3
Y1 - 2010/3
N2 - Context: Pheochromocytomas and paragangliomas are genetically heterogeneous tumors of neural crest origin. Approximately half of these tumors activate a pseudohypoxic transcription response, which is due in a minority of the cases to germline mutations of the VHL gene or the genes encoding subunits of the metabolicenzymesuccinate dehydrogenase (SDH),SDHB,SDHC,orSDHD. However, the genetic basis of the hypoxic-like profile of the remaining tumors is undetermined. Mutations in genes involved in the energy metabolism, isocitrate dehydrogenase 1 (IDH1) and -2 (IDH2) and SDHAF2, a component of SDH, can mimic a pseudohypoxic state. Design:Weexamined the sequence spanning the mutation-susceptible codons 132 ofIDH1and172 of IDH2,andthe entire coding region ofSDHAF2, in 104 pheochromocytomasandparagangliomas, including tumors with a pseudohypoxic expression profile. Results: We did not find mutations in IDH1, IDH2, or SDHAF2 in any of the tumors in this cohort. Conclusion: Conserved residues of IDH1 and IDH2 or the SDHAF2 gene are not frequently mutated in pheochromocytomas and paragangliomas. The molecular basis for activation of a hypoxic response in the majority of tumors without VHL or SDH mutations remains to be defined.
AB - Context: Pheochromocytomas and paragangliomas are genetically heterogeneous tumors of neural crest origin. Approximately half of these tumors activate a pseudohypoxic transcription response, which is due in a minority of the cases to germline mutations of the VHL gene or the genes encoding subunits of the metabolicenzymesuccinate dehydrogenase (SDH),SDHB,SDHC,orSDHD. However, the genetic basis of the hypoxic-like profile of the remaining tumors is undetermined. Mutations in genes involved in the energy metabolism, isocitrate dehydrogenase 1 (IDH1) and -2 (IDH2) and SDHAF2, a component of SDH, can mimic a pseudohypoxic state. Design:Weexamined the sequence spanning the mutation-susceptible codons 132 ofIDH1and172 of IDH2,andthe entire coding region ofSDHAF2, in 104 pheochromocytomasandparagangliomas, including tumors with a pseudohypoxic expression profile. Results: We did not find mutations in IDH1, IDH2, or SDHAF2 in any of the tumors in this cohort. Conclusion: Conserved residues of IDH1 and IDH2 or the SDHAF2 gene are not frequently mutated in pheochromocytomas and paragangliomas. The molecular basis for activation of a hypoxic response in the majority of tumors without VHL or SDH mutations remains to be defined.
UR - http://www.scopus.com/inward/record.url?scp=77749270530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77749270530&partnerID=8YFLogxK
U2 - 10.1210/jc.2009-2245
DO - 10.1210/jc.2009-2245
M3 - Article
C2 - 20130071
AN - SCOPUS:77749270530
SN - 0021-972X
VL - 95
SP - 1469
EP - 1472
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 3
ER -